<sentence id="0">IL-2-mediated cell cycle progression and inhibition of apoptosis does <scope type="neg" id="0"><cue type="neg" id="0">not</cue> require NF-kappa B or activating protein-1 activation in primary human T cells</scope> .</sentence>
<sentence id="1">The IL-2 growth hormone is the major growth factor of activated T lymphocytes during a developing immune response .</sentence>
<sentence id="2">IL-2 is required not only for cell cycle progression but also to protect Ag-activated T cells from programmed cell death .</sentence>
<sentence id="3">In several cell types , activation of NF-kappa B and/or activating protein-1 ( AP-1 ) has been demonstrated to be extremely important in blocking apoptosis .</sentence>
<sentence id="4">To determine <scope type="spec" id="1"> <cue type="spec" id="1">whether</cue> <scope type="spec" id="2"> either <cue type="spec" id="2">or</cue> both</scope> of these transcription factors are involved in cell survival or cell cycle progression in response to IL-2</scope> , primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation .</sentence>
<sentence id="5">The current study clearly demonstrates that IL-2 does <scope type="neg" id="3"><cue type="neg" id="3">not</cue> induce I kappa B alpha degradation or NF-kappa B activation in primary human T cells that respond to IL-2 by entering the cell cycle and avoiding apoptosis</scope> .</sentence>
<sentence id="6">Similarly , IL-2 <scope type="neg" id="4"><cue type="neg" id="4">neither</cue> activates JNK <scope type="neg" id="5"><cue type="neg" id="5">nor</cue> increases AP-1 binding activity to a consensus o-tetradecanoylphorbol 13-acetate ( TPA ) response element</scope></scope> .</sentence>
<sentence id="7">On the other hand , the growth factor does induce the activation of STAT3 and STAT5 in these cells , as has been previously demonstrated .</sentence>
<sentence id="8">These data show that <scope type="neg" id="6"><cue type="neg" id="6">neither</cue> NF-kappa B <scope type="neg" id="7"><cue type="neg" id="7">nor</cue> AP-1 activation is required for IL-2-mediated survival or cell cycle progression in activated primary human T cells</scope></scope> .</sentence>